Frontage Laboratories collaborates with Yabao Pharmaceuticals Group

Tuesday, March 1, 2011 08:00 AM

Frontage Laboratories has signed a $50 million collaboration with China’s Yabao Pharmaceuticals Group, under which Frontage will supply pharmaceutical and regulatory development services to Yabao over five years, according to PharmaTimes.

The U.S.-based contract research, development and manufacturing group, which has a substantial presence in China, will develop sustained-release drug technologies for Yabao and provide clinical research support for its efforts to develop 20 new products for the U.S. and E.U. markets. Frontage established a subsidiary in Shanghai in 2006 and a clinical research center in Zhengzhou in 2009, and is currently completing construction of a drug development operation in Beijing.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs